• This system uses sound waves to create 3D images of the breast, showing a better picture of the tumor. (knowcancer.com)
  • Tumor tissue microRNA expression in association with triple-negative breast cancer outcomes. (curehunter.com)
  • Primary desmoid tumor (extraabdominal fibromatosis) of the breast. (radiopaedia.org)
  • Breast Neuroendocrine Neoplasm, also known as neuroendocrine tumor of the breast , is related to neuroendocrine tumor and peritoneal serous adenocarcinoma . (malacards.org)
  • Well-differentiated neuroendocrine tumor of the breast with extensive lymphatic and vascular infiltration. (malacards.org)
  • Well-differentiated neuroendocrine tumor of the breast with recurrence due to needle tract seeding. (malacards.org)
  • Primary neuroendocrine tumor of the breast. (malacards.org)
  • Expression patterns for terminal differentiation markers were used to characterize tumor types and to study tumor progression in transgenic mouse models of mammary neoplasia (mice overexpressing Neu ( Erbb2 ), Hras , Myc , Notch4 , SV40-TAg , Tgfa , and Wnt1 ), in spontaneous mammary carcinomas, and in mammary neoplasms associated with infection by the mouse mammary tumor virus (MMTV). (biomedcentral.com)
  • and third, 'carcinomas with epithelial to mesenchymal transition (EMT)' are a characteristic feature of tumor progression in Hras- , Myc- , and SV40-TAg- induced mammary neoplasms and PL/J and SJL/J mouse strains, and display de novo expression of myoepithelial and mesenchymal cell markers. (biomedcentral.com)
  • However, because of overlapping of cytologic features, surgical excision should be warranted in all cases of papillary lesions of the breast to further characterize the tumor. (jpatholtm.org)
  • A urogenital neoplasm is a tumor of the urogenital system. (icd.codes)
  • We applied our previously published mathematical heterogeneity model to decipher tumor heterogeneity through the analysis of genetic copy number aberrations revealed by array CGH data for tumors of three different tissues: breast, colon, and skin. (biomedcentral.com)
  • Tumor heterogeneity is defined as the simultaneous presence of multiple clonal subpopulations of tumor cells within a single neoplasm [ 1 ]. (biomedcentral.com)
  • Unlike breast cancer, colon cancer is thought to be more homogeneous with a single dominant pathway and histological presentation during tumor progression [ 11 ]. (biomedcentral.com)
  • 40 years regarding the achievement of a pCR (defined as no invasive residual tumor in the breast or lymph nodes). (nih.gov)
  • Abstract Two hundred and thirty-five consecutive patients presenting to a single center with acute myeloid leukemia (AML) or myelodysplastic syndrome (MDS) after breast cancer treatment were compared with matched patients with de novo AML or MDS. (elsevier.com)
  • Hematopoietic and lymphoid neoplasms involving the breast are sometimes listed under the rubric of breast "metastases," but they are best regarded as either primary breast neoplasms or as a manifestation of a systemic condition, depending upon the extent of organ involvement. (basicmedicalkey.com)
  • It is important to bear in mind that not all families with a pedigree suggestive of hereditary breast cancer are linked to BRCA1 or BRCA2. (health.am)
  • A recessive variant of XRCC4 predisposes to non- BRCA1/2 breast cancer in chinese women and impairs the DNA damage response via dysregulated nuclear localization. (duke.edu)
  • Large-scale genomic analyses link reproductive aging to hypothalamic signaling, breast cancer susceptibility and BRCA1-mediated DNA repair. (curehunter.com)
  • In 1994 it was discovered that women who inherit a mutated BRCA1 gene have an almost 85% chance of developing breast cancer and an increased chance of developing uterine cancer. (thefreedictionary.com)
  • Young women who get breast cancer often come from families that carry a BRCA1 mutation. (thefreedictionary.com)
  • paciente masculino de 53 años de edad, con diagnóstico de cáncer de mama derecha, tipo adenocarcinoma canalicular infiltrante, estadio clínico IIB, con antecedentes de cáncer de mama en 2 familiares directos, mutaciones del gen BRCA1 y positivo tanto a receptores hormonales como para el gen Her2/Neu. (nih.gov)
  • 53 -year-old male diagnosed with right breast cancer, infiltrating ductal adenocarcinoma type, clinical stage IIB, breast cancer on 2 immediate family history, mutations of the BRCA1 gene and positive hormone receptors and Her2/Neu. (nih.gov)
  • FRIDAY, Jan. 12, 2018 (HealthDay News) -- Lynparza (olaparib) has been approved by the U.S. Food and Drug Administration to treat spreading breast cancer caused by a BRCA gene mutation. (hon.ch)
  • Read the April 2018 PRS #PlasticSurgery Article, 'Breast cancer following augmentation mammaplasty: a case-control study' by Sosin, Devulapalli, Fehring, et al. (lww.com)
  • Fortunately, the majority of breast lumps are non-malignant cysts or fibrous tissue. (giantmicrobes.com)
  • Breasts are considered "dense" when there is a high ratio of tissue to fat. (knowcancer.com)
  • Excised fresh breast tissue for evaluation and/or treatment of a variety of breast lesions were sampled by FNA technique and placed into PreservCyt. (nih.gov)
  • In conclusion, FNA of breast tissue placed in PreservCyt is a potentially acceptable method of sample handling for evaluation by the SELDI-TOF methodology for establishment of reproducible protein patterns. (nih.gov)
  • Radiologic techniques such as MRI (magnetic resonance imaging) and FDG-PET/CT (fluorodeoxyglucose-positron emission tomography-computed tomography) have also detected metastases in the breast from carcinoma of the thyroid ( 7 ), ovary ( 8 ), and soft tissue liposarcoma ( 9 ). (basicmedicalkey.com)
  • Soft-Tissue Sarcomas, Breast Cancer, and Other NeoplasmsA Familial Syndrome? (annals.org)
  • Breast cancer in male patient has a worse prognosis than female patients, due to lower amount of tissue in breast exposed to an earlier chest spread and a different biological behavior, also a higher risk of prostate and pancreatic cancer is associated. (nih.gov)
  • A Study of Herceptin (Trastuzumab) in Combination With Xeloda (Capecitabine) in Patients With Metastatic or Recurrent HER2-positive Breast Cancer After First-Line or (Neo)Adjuvant Therapy. (drugbank.ca)
  • After 109,560 person-years of follow-up, the overall rate of marrow neoplasms in the entire cohort was 0.46 per 1,000 person-years, with rates per 1,000 person-years of 0.16 in those receiving surgery alone, 0.43 in those receiving adjuvant radiation alone, 0.46 in those receiving adjuvant chemotherapy alone, and 0.54 in those receiving both adjuvant treatments. (ascopost.com)
  • Active Smoking and Breast Cancer Risk: Original Cohort Data and Meta-Analysis. (aaem.pl)
  • PubMed, EMBASE and ISI Web of Knowledge were searched to find cohort studies or case control studies that evaluated the relationship between egg consumption and breast cancer risk. (springer.com)
  • Meat, eggs, dairy products, and risk of breast cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC) cohort. (springer.com)
  • The drug is approved for hormone receptor-positive and HER2-negative forms of advanced or spreading breast cancer that have been treated with a therapy that changes a person's hormones (endocrine therapy). (hon.ch)
  • The drug was evaluated in clinical studies involving almost 700 people whose breast cancer had progressed after treatment with endocrine therapy. (hon.ch)